2026.02.10本文字数:878,阅读时长大约2分钟作者 |第一财经钱童心美国食品和药物管理局(FDA)日前向减重药司美格鲁肽厂商诺和诺德发出警告信,称该公司的口服减重药电视广告带有误导性。FDA的这封警告信正值减重药竞争加剧之际。诺和诺德、礼来等减重药厂商借今年的美国超级碗投放了大量电视广告。但诺和诺德称,FDA的最新警告不涉及超级碗广告,而是常规播放的关于司美格鲁肽口服减重药电视广告。随着...
Source Link2026.02.10本文字数:878,阅读时长大约2分钟作者 |第一财经钱童心美国食品和药物管理局(FDA)日前向减重药司美格鲁肽厂商诺和诺德发出警告信,称该公司的口服减重药电视广告带有误导性。FDA的这封警告信正值减重药竞争加剧之际。诺和诺德、礼来等减重药厂商借今年的美国超级碗投放了大量电视广告。但诺和诺德称,FDA的最新警告不涉及超级碗广告,而是常规播放的关于司美格鲁肽口服减重药电视广告。随着...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.